Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion By: CNBC.com News December 06, 2023 at 17:06 PM EST The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion By: CNBC.com News December 06, 2023 at 17:06 PM EST The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition. Read More >>